Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacovigilance01:19

Pharmacovigilance

1.3K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.3K
Drug-Receptor Interaction: Antagonist01:28

Drug-Receptor Interaction: Antagonist

4.1K
An antagonist is a drug that binds strongly to a receptor without activating it. An antagonist prevents other molecules, such as neurotransmitters or hormones, from binding to the receptor and triggering a cellular response. Such interaction effectively hinders the normal physiological processes mediated by the receptor, resulting in various pharmacological effects depending on the specific receptor targeted.
Antagonists can be classified as competitive or noncompetitive based on their...
4.1K
Allergic Drug Reactions01:27

Allergic Drug Reactions

1.1K
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
1.1K
Drug-Receptor Interaction: Agonist01:25

Drug-Receptor Interaction: Agonist

3.3K
Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
3.3K
Drug-Receptor Interactions01:29

Drug-Receptor Interactions

6.7K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
6.7K
Combined Effects of Drugs: Antagonism01:30

Combined Effects of Drugs: Antagonism

10.0K
The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
10.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Rule-Based Algorithm to Identify Recurrent Non-Hodgkin Lymphoma in Electronic Health Data.

JCO clinical cancer informatics·2026
Same author

Deep learning enabled decision support systems in epilepsy surgery: a scoping review.

npj health systems·2026
Same author

Environmental and social determinants of health enhance machine learning models for pneumonia readmission.

Digital health·2026
Same author

Experimental Study of YaJieShaBa Antialcoholic Hepatic Fibrosis Through TGF-β1/Smad Signaling Pathway.

Mediators of inflammation·2026
Same author

Mechanistic Insights into the Anti-Constipation Potential of Zeng Ye Tang Compound: UHPLC-Q-TOF MS/MS, Network Pharmacology, and In vivo Experimental Validation.

Combinatorial chemistry & high throughput screening·2026
Same author

Evaluating model generalizability for suicide attempt risk prediction: traditional machine vs deep learning.

Npj mental health research·2026
Same journal

Sensitivity Analyses of a Scoring System for a Contraception Decision Aid.

AMIA ... Annual Symposium proceedings. AMIA Symposium·2026
Same journal

Improving electronic health record processing of large language models via retrieval-augmented generation: A case study on dietary supplements.

AMIA ... Annual Symposium proceedings. AMIA Symposium·2026
Same journal

Developing a User-Centered Mobile Application Prototype: Bridging Lower-Limb Fracture Care from Skilled Nursing Facility and Back to the Community.

AMIA ... Annual Symposium proceedings. AMIA Symposium·2026
Same journal

KERAP: A Knowledge-Enhanced Reasoning Approach for Accurate Zero-shot Diagnosis Prediction Using Multi-agent LLMs.

AMIA ... Annual Symposium proceedings. AMIA Symposium·2026
Same journal

Automating Adjudication of Cardiovascular Events Using Large Language Models.

AMIA ... Annual Symposium proceedings. AMIA Symposium·2026
Same journal

Predictive Factors and State-Level Barriers to Postpartum Birth Control Usage in the United States: Insights from PRAMS Phase 8.

AMIA ... Annual Symposium proceedings. AMIA Symposium·2026
See all related articles

Related Experiment Video

Updated: Nov 7, 2025

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems
05:47

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems

Published on: June 13, 2025

848

Neural Multi-Task Learning for Adverse Drug Reaction Extraction.

Feifan Liu1, Xiaoyu Zheng1, Hong Yu2

  • 1University of Massachusetts Medical School, Worcester, MA, USA.

AMIA ... Annual Symposium Proceedings. AMIA Symposium
|May 3, 2021
PubMed
Summary
This summary is machine-generated.

A new system, NeuroADR, efficiently extracts adverse drug reactions (ADRs) and their modifiers from drug labels. This improves patient safety by creating a searchable ADR knowledge base.

More Related Videos

A Method for Remotely Silencing Neural Activity in Rodents During Discrete Phases of Learning
09:22

A Method for Remotely Silencing Neural Activity in Rodents During Discrete Phases of Learning

Published on: June 22, 2015

14.8K

Related Experiment Videos

Last Updated: Nov 7, 2025

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems
05:47

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems

Published on: June 13, 2025

848
A Method for Remotely Silencing Neural Activity in Rodents During Discrete Phases of Learning
09:22

A Method for Remotely Silencing Neural Activity in Rodents During Discrete Phases of Learning

Published on: June 22, 2015

14.8K

Area of Science:

  • Pharmacovigilance
  • Natural Language Processing
  • Computational Linguistics

Background:

  • Adverse drug reactions (ADRs) pose a significant risk to patient safety.
  • Existing methods for extracting ADR information from unstructured text are often limited.
  • A searchable knowledge base of ADRs is crucial for clinical decision-making.

Purpose of the Study:

  • To develop a novel neural multi-task learning system, NeuroADR, for extracting ADRs and associated modifiers from free-text drug labels.
  • To enhance the accuracy and efficiency of ADR information retrieval from clinical texts.
  • To contribute to the creation of a reliable and searchable ADR knowledge database.

Main Methods:

  • Implementation of a hierarchical multi-task learning (HMTL) framework for joint named entity recognition (NER) and relation extraction (RE).
  • Exploration of interactions among deep encoder representations across different subtasks.
  • Adoption of a novel task decomposition strategy to increase inter-task interactions.
  • Integration of a new label encoding schema to effectively handle discontinuous entities.

Main Results:

  • The NeuroADR system demonstrated significant effectiveness in extracting ADRs and relevant modifiers.
  • The proposed hierarchical multi-task learning approach improved the joint performance of NER and RE.
  • The novel task decomposition and label encoding schema enhanced the system's ability to handle complex linguistic structures in drug labels.

Conclusions:

  • The NeuroADR system offers a promising approach for automated extraction of ADR information from drug labels.
  • This advancement can lead to more robust and searchable ADR knowledge bases, enhancing patient safety.
  • The developed methodology provides a foundation for future research in clinical text mining and pharmacovigilance.